We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · March 05, 2021

Outcomes of Patients With Acute Exacerbation of COPD Treated With Amoxicillin vs Amoxicillin/Clavulanic Acid

Respiratory Research


Additional Info

Disclosure statements are available on the authors' profiles:

Respiratory Research
Antibiotic Treatment in Acute Exacerbation of COPD: Patient Outcomes With Amoxicillin vs. Amoxicillin/Clavulanic Acid—Data From 43,636 Outpatients
Respir. Res. 2021 Jan 07;22(1)11, K Bagge, P Sivapalan, J Eklöf, FB Hertz, CØ Andersen, EF Hansen, JO Jarløv, JS Jensen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading